BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Rho Offers Insight On Key Components Of New Drug Application Submissions


2/7/2014 9:52:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WHAT: A new drug application (NDA) covers information about a product from inception through clinical trials, thus making it imperative for sponsor and contract research organizations to present the FDA with a coherent and clear integration of data from product development programs.

Rho, a full-service contract research organization (CRO), will provide valuable insight and important considerations for developing the integrated summary of safety (ISS) and the integrated summary of efficacy (ISE) sections of an NDA submission through a free webinar.

WHO: Ben Vaughn, senior statistical scientist, Rho
Rob Woolson, statistical scientist, Rho

WHEN: Tuesday, February 11, 2014
1:00 p.m. ET/ 10 a.m. PT

Webinar Registration: Keys to Success for Your Integrated Summary of Safety (ISS) and Integrated Summary of Efficacy (ISE)

DETAILS: For media inquiries, please contact Jessica Highsmith at Largemouth Communications, (919) 459-6456, jessica@largemouthpr.com.

ABOUT: Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For more than 25 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

Rho
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES